Skip to main content
Premium Trial:

Request an Annual Quote

WTSI Signs on to iRODS Consortium


The Wellcome Trust Sanger Institute has joined the Integrated Rule-Oriented Data System (iRODS) Consortium, the entity that supports a highly-configurable open source infrastructure used globally for data management, sharing, and integration.

The iRODS Consortium was founded about a year ago by the Renaissance Computing Institute (RENCI) at the University of North Carolina-Chapel Hill and the Max Planck Society. Its purpose is to bring together universities, research organizations, businesses, and government agencies to guide the continued development of the iRODS data management platform, which was created by the Data Intensive Cyber Environments group at UNC-Chapel Hill and the University of California at San Diego; to obtain funding to support development efforts; and to broaden the community of users.

"We are delighted to join the iRODS Consortium," Guy Coates, team leader of WTSI's informatics systems group, said in a statement. "We need efficient management systems to ensure that our large-scale datasets are of value … [we] need to make sure we can produce, manage and use genome information as efficiently as possible."

Brand Fortner, the director of the iRODS Consortium and a senior researcher at RENCI, said in his comments that WTSI "will be an extremely valuable member of the consortium."

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.